Galmed Pharmaceuticals
GLMD
#9510
Rank
A$8.11 M
Marketcap
$12.60
Share price
21.74%
Change (1 day)
8.50%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$10.15

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$10.03. In 2022 the company made an earnings per share (EPS) of -$15.85 an increase over its 2021 EPS that were of -$29.70.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$10.15-35.95%
2022-$15.85-46.62%
2021-$29.70-2.22%
2020-$30.3739.18%
2019-$21.8270.18%
2018-$12.82-41.84%
2017-$22.05-34.23%
2016-$33.5256.84%
2015-$21.379.2%
2014-$19.57-53.43%
2013-$42.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.93-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.03-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.12-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.54-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA